MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

Veradermics, Inc (MANE)

Veradermics, Inc (MANE)

||
||

Cash Flow Overview

Change in Cash
$150,921K
Free Cash flow
-$14,511K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Public offering, net of issuance...
    • Maturities of marketable securit...
    • Pre-funded warrants, net of issu...
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Interest receivable on marketabl...
    • Accrued expenses
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
Net loss
-23,502
-27,232
-69,995
Stock-based compensation
3,516
5,259
1,440
Research and development expenses paid with convertible and promissory notes
-
-
0
Non-cash research and development services
632
621
1,999
Net accretion of discount/premium on debt securities
-2
73
556
Accrued interest earned
-
-
647
Other
-56
-6
-43
Prepaid expenses and other current assets
-1,420
-4,360
8,235
Interest receivable on marketable securities
1,281
1,499
-
Accounts payable
4,849
-1,055
-122
Accrued expenses
-211
-1,373
4,510
Other non-current assets
80
174
-
Other current liabilities and lease liabilities
109
-8
-39
Net cash used in operating activities
-14,490
-21,168
-71,602
Purchase of property, plant and equipment
21
0
24
Purchases of marketable securities
305,577
122,988
143,852
Maturities of marketable securities
28,311
21,689
25,018
Net cash used in investing activities
-277,287
-101,299
-118,858
Issuance of convertible notes
-
-
0
Issuance of preferred stock-Series BPreferred Stock
-
-
8,433
Issuance of series b preferred stock, net of issuance costs paid
0
0
-
Issuance of preferred stock-Series CPreferred Stock
-
-
151,000
Initial public offering, net of issuance costs paid
0
269,102
-
Payment of promissory note
-
-
0
Public offering, net of issuance costs
414,335
-
-
Preferred stock issuance costs
-
-
447
Pre-funded warrants, net of issuance costs
28,120
-
-
Exercise of stock options
243
11
156
Net cash provided by financing activities
442,698
269,113
159,142
Net increase (decrease) in cash and cash equivalents
150,921
146,646
-31,318
Cash and cash equivalentsbeginning of period
168,412
21,766
53,084
Cash and cash equivalentsend of period
319,333
168,412
21,766
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

MANE Cash Flow Sankey DiagramSankey diagram visualizing MANE cash flow for the periodPublic offering, net ofissuance costs$414,335K Pre-funded warrants, net ofissuance costs$28,120K Exercise of stock options$243K Net cash provided byfinancing activities$442,698K Net increase(decrease) in cash and cash...$150,921K Canceled cashflow$291,777K Maturities of marketablesecurities$28,311K Accounts payable$4,849K Stock-based compensation$3,516K Prepaid expenses andother current assets-$1,420K Non-cash research anddevelopment services$632K Other currentliabilities and lease...$109K Other-$56K Net accretion ofdiscount/premium on debt...-$2K Net cash used ininvesting activities-$277,287K Net cash used inoperating activities-$14,490K Canceled cashflow$28,311K Canceled cashflow$10,584K Purchases of marketablesecurities$305,577K Net loss-$23,502K Purchase of property,plant and equipment$21K Interest receivable onmarketable securities$1,281K Accrued expenses-$211K Other non-currentassets$80K